![Substituted pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors](/docs/US/2023-02-28/US11591333B2/abs.jpg.600x600.jpg)
- Patent Title: Substituted pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors
-
Application No.: US16092394Application Date: 2017-02-22
-
Publication No.: US11591333B2Publication Date: 2023-02-28
- Inventor: Na Liu , Lixia Bao , Zhepeng Wei , Yufeng Zhou , Bin Rong , Lihui Zhao , Fei Xiao
- Applicant: CINKATE PHARM TECH (SHANGHAI) CO.,LTD. , CINKATE PHARMACEUTICAL INTERMEDIATES CO., LTD.
- Applicant Address: CN Shanghai; CN Shanghai
- Assignee: CINKATE PHARM TECH (SHANGHAI) CO.,LTD.,CINKATE PHARMACEUTICAL INTERMEDIATES CO., LTD.
- Current Assignee: CINKATE PHARM TECH (SHANGHAI) CO.,LTD.,CINKATE PHARMACEUTICAL INTERMEDIATES CO., LTD.
- Current Assignee Address: CN Shanghai; CN Shanghai
- Agency: Hamre, Schumann, Mueller & Larson, P.C.
- Priority: CN201610100165.5 20160223
- International Application: PCT/CN2017/074446 WO 20170222
- International Announcement: WO2017/143990 WO 20170831
- Main IPC: A61K31/519
- IPC: A61K31/519 ; C07D487/04
![Substituted pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors](/abs-image/US/2023/02/28/US11591333B2/abs.jpg.150x150.jpg)
Abstract:
The present invention provides a method for preparing a pyrrolopyrimidine compound and application thereof. Specifically, the present invention provides a compound represented by formula I or pharmaceutically-acceptable salts thereof, a pharmaceutical composition containing the compound or its salts, and a method for preparing the pharmaceutical composition and an application of the pharmaceutical composition as an immunosuppressive drug.
Public/Granted literature
- US20220017522A1 METHOD FOR PREPARING PYRROLOPYRIMIDINE COMPOUND AND APPLICATION THEREOF Public/Granted day:2022-01-20
Information query
IPC分类:
